These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Hyperglycaemia attenuates erythromycin-induced acceleration of solid-phase gastric emptying in idiopathic and diabetic gastroparesis. Petrakis IE; Vrachassotakis N; Sciacca V; Vassilakis SI; Chalkiadakis G Scand J Gastroenterol; 1999 Apr; 34(4):396-403. PubMed ID: 10365900 [TBL] [Abstract][Full Text] [Related]
10. [The potentials of erythromycin derivatives in the treatment of gastrointestinal motility disorders]. Peeters TL Z Gesamte Inn Med; 1991 Aug; 46(10-11):349-54. PubMed ID: 1926941 [TBL] [Abstract][Full Text] [Related]
11. The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin. Richards RD; Davenport K; McCallum RW Am J Gastroenterol; 1993 Feb; 88(2):203-7. PubMed ID: 8424421 [TBL] [Abstract][Full Text] [Related]
12. Effect of metoclopramide in diabetic gastroparesis. Ricci DA; Saltzman MB; Meyer C; Callachan C; McCallum RW J Clin Gastroenterol; 1985 Feb; 7(1):25-32. PubMed ID: 3884697 [TBL] [Abstract][Full Text] [Related]
13. Erythromycin: the mechanism of its prokinetic action in the treatment of gastroparesis. Fraser RJ; Mittal RK Gastroenterology; 1994 Dec; 107(6):1904-5. PubMed ID: 7958712 [No Abstract] [Full Text] [Related]
14. The effect of intravenous erythromycin on solid meal gastric emptying in patients with chronic symptomatic post-vagotomy-antrectomy gastroparesis. Kendall BJ; Chakravarti A; Kendall E; Soykan I; McCallum RW Aliment Pharmacol Ther; 1997 Apr; 11(2):381-5. PubMed ID: 9146779 [TBL] [Abstract][Full Text] [Related]
15. Gastric motor abnormalities in diabetic and postvagotomy gastroparesis: effect of metoclopramide and bethanechol. Malagelada JR; Rees WD; Mazzotta LJ; Go VL Gastroenterology; 1980 Feb; 78(2):286-93. PubMed ID: 7350052 [TBL] [Abstract][Full Text] [Related]
16. Erythromycin stimulates gastric emptying after esophagectomy with gastric replacement: a randomized clinical trial. Burt M; Scott A; Williard WC; Pommier R; Yeh S; Bains MS; Turnbull AD; Fortner JG; McCormack PM; Ginsberg RJ J Thorac Cardiovasc Surg; 1996 Mar; 111(3):649-54. PubMed ID: 8601981 [TBL] [Abstract][Full Text] [Related]
17. Improved nutrition after the detection and treatment of occult gastroparesis in nondiabetic dialysis patients. Ross EA; Koo LC Am J Kidney Dis; 1998 Jan; 31(1):62-6. PubMed ID: 9428453 [TBL] [Abstract][Full Text] [Related]
18. Tumor-associated gastroparesis with esophageal carcinoma. Use of intravenous metoclopramide during radionuclide gastric emptying studies to predict clinical response. Choe AI; Ziessman HA; Fleischer DE Dig Dis Sci; 1989 Jul; 34(7):1132-4. PubMed ID: 2663388 [TBL] [Abstract][Full Text] [Related]
19. Delayed gastric emptying in patients with caustic ingestion. Mittal BR; Kochhar R; Shankar R; Bhattacharya A; Solanki K; Nagi B Nucl Med Commun; 2008 Sep; 29(9):782-5. PubMed ID: 18677205 [TBL] [Abstract][Full Text] [Related]
20. Clinical trial of metoclopramide on postvagotomy gastric stasis. Stadaas JO; Aune S Arch Surg; 1972 May; 104(5):684-6. PubMed ID: 4554726 [No Abstract] [Full Text] [Related] [Next] [New Search]